DXCM Operating Cash Flow (Statement)

Dexcom · Operating Cash Flow (Statement)

DXCM logo

DXCM Operating Cash Flow (Statement)

Latest reported$1.75B
DXCM TTM Cash from Operations (-$22.55M → $1.75B)
High-resolution chart · PNG

DXCM operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Dexcom Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
1,748,700,000
1,782,500,000
1,440,700,000
1,448,100,000
987,700,000
964,100,000
989,500,000
821,700,000
891,400,000
802,300,000
748,500,000
747,400,000
771,400,000
753,900,000
669,500,000
642,800,000
596,900,000
485,700,000
442,500,000
508,700,000
409,000,000
501,500,000
475,600,000
447,300,000
394,200,000
304,600,000
314,500,000
204,500,000
166,800,000
143,700,000
123,200,000
130,700,000
110,100,000
83,000,000
92,000,000
64,100,000
50,900,000
56,700,000
56,200,000
54,200,000
49,100,000
45,400,000
49,000,000
46,100,000
39,600,000
29,400,000
23,600,000
19,600,000
9,800,000
4,500,000
2,400,000
-12,557,000
-20,207,000
-27,436,000
-33,100,000
-34,113,000
-34,804,000
-31,001,000
-30,126,000
-32,020,000
-34,749,000
-41,528,000
-42,676,000
-38,385,000
-38,723,000
-40,454,000
-39,389,000
-27,690,000
-29,499,000
-30,364,000
-37,451,000
-47,141,000
-45,530,000
-41,256,000
-33,207,000
-36,015,393
-34,782,564
-40,769,605
-43,734,840
-40,421,597
-37,245,436
-28,821,170
-22,553,785
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.